ARCHIVES

FDA News: Zydelig approved in three B-cell blood cancers

This article is from The Cancer Letter archive.

Vol. 40 No. 31 | August 1, 2014

Download PDF Visit The Full Archive

Related Articles

Cooper, Frederickson Formally Named To Top Health, NIH Positions

April 25, 1975

Sloan-Kettering Sues Empire Blue Cross Over Reimbursement

September 17, 1993

Cancer Control RFA Announcements

March 9, 1979

Georgetown Sponsors Oncology Agent Development Meeting

March 21, 2003

Funding opportunities: ASCO breast cancer research award; Lustgarten Foundation prostate cancer research award; NCI program announcements available.

March 5, 2004

Large Phase III Trial Seeks Optimal Use Of Tykerb vs. Herceptin In Breast Cancer

February 29, 2008